Inhibrx Biosciences (INBX) Shares Issued (2023 - 2025)

Inhibrx Biosciences (INBX) reported Shares Issued of $1.3 million for Q4 2025, up 256.25% quarter-over-quarter from $352000.0 in Q3 2025.

Inhibrx Biosciences (INBX) Shares Issued (2023 - 2025) Analysis & Trends

Inhibrx Biosciences (INBX) has 3 years of Shares Issued data on file, last reported at $1.3 million in Q4 2025.

  • Shares Issued for Q4 2025 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $1.6 million (down 97.76% YoY), and the FY2025 annual result was $1.6 million, down 97.76% from the prior year.
  • Shares Issued advanced to $1.3 million in Q4 2025 per INBX's latest filing, from $352000.0 in the prior quarter.
  • Over five years, Shares Issued peaked at $38.7 million in Q1 2024 and troughed at $21000.0 in Q3 2023.
  • A 3-year average of $12.4 million and a median of $1.2 million in 2023 frame the typical range for Shares Issued.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 5.40 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 27.00 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26,927.15
10 Inhibrx Biosciences 186.16 Mn 186.16 Mn - 1.25 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.25 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 352,000.00
Sep 30, 2025 352,000.00
Jun 30, 2024 32.95 Mn
Jun 30, 2024 32.95 Mn
Mar 31, 2024 38.73 Mn
Mar 31, 2024 38.73 Mn
Dec 31, 2023 1.09 Mn
Dec 31, 2023 1.09 Mn
Sep 30, 2023 21,000.00
Sep 30, 2023 21,000.00